Islas-Rodríguez A E, Guillén-Vargas C M, Fafutis-Morris M, Alfaro-Bustamante F, Morales-Ortíz R, Gonzalez-Mendoza A, Estrada-Parra I
Centro de Investigación en Inmunología y Dermatológia, Universidad de Guadalajara/Instituto Dermatológico de Guadalajara (SSBS), Jalisco, México.
Int J Lepr Other Mycobact Dis. 1993 Jun;61(2):245-9.
A great diversity of antigens from Mycobacterium leprae have been described. One practical approach should be to utilize them as markers to indicate when a household contact is at risk of becoming infected and then moving to an active form of leprosy. For this purpose, sonic extracts of M. leprae were fractionated in 10% SDS-PAGE under reducing conditions. The fractionated proteins were then transferred to nitrocellulose sheets and incubated with sera from lepromatous leprosy cases, their contacts, and normal subjects in order to reveal the frequency of antigen recognition of each set of sera. The results showed that sera from lepromatous leprosy patients frequently recognized two proteins, one of approximately 28 kDa and the other of approximately 65 kDa, when compared with the sera from normal subjects. The contacts frequently recognized an approximately 16-kDa antigenic band, while sera from normal subjects recognized one protein of approximately 18 kDa. According to the results, the four recognized proteins from M. leprae can be considered markers of the above conditions (approximately 65 kDa, approximately 28 kDa for lepromatous leprosy, approximately 16 kDa for contacts, and approximately 19 kDa for normal subjects). From these, an easy serological test, such as an ELISA, can be developed to predict if a contact is moving toward lepromatous leprosy before detection of the actual clinical signs or symptoms.
已描述了来自麻风分枝杆菌的多种抗原。一种切实可行的方法是将它们用作标志物,以表明家庭接触者何时有感染风险并进而发展为活动性麻风病。为此,在还原条件下将麻风分枝杆菌的超声提取物在10%十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)中进行分级分离。然后将分级分离的蛋白质转移到硝酸纤维素膜上,并与瘤型麻风病患者、其接触者和正常受试者的血清孵育,以揭示每组血清对抗原的识别频率。结果表明,与正常受试者的血清相比,瘤型麻风病患者的血清经常识别两种蛋白质,一种约为28 kDa,另一种约为65 kDa。接触者经常识别一条约16 kDa的抗原条带,而正常受试者的血清识别一种约18 kDa的蛋白质。根据这些结果,来自麻风分枝杆菌的四种被识别的蛋白质可被视为上述情况的标志物(约65 kDa、约28 kDa用于瘤型麻风病、约16 kDa用于接触者、约19 kDa用于正常受试者)。由此,可以开发一种简单的血清学检测方法,如酶联免疫吸附测定(ELISA),以在实际临床体征或症状出现之前预测接触者是否正在发展为瘤型麻风病。